Join
Live feed
·
INSIDERFilingvia Quantisnow
Eton Pharmaceuticals Inc. logo

Chief Business Officer Krempa David sold $504,318 worth of shares (34,000 units at $14.83), decreasing direct ownership by 5% to 612,646 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ETON· Eton Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ETON (Eton Pharmaceuticals Inc.) and more on Quantisnow.